What Is Nicotine Withdrawal Syndrome?
Nicotine withdrawal syndrome is the set of physical and psychological symptoms that arise when a smoker stops or significantly reduces tobacco use. It is a direct manifestation of the neurochemical dependence that nicotine produces in the brain — and it represents the main barrier to smoking cessation.
Smoking is recognized by the WHO as a chronic disease of dependence, classified in ICD-11 as Tobacco Use Disorder. Nicotine is one of the most addictive substances known — with high dependence potential, comparable to or greater than that of other psychoactive substances on some epidemiological measures. About 70% of smokers want to quit, but only 3-5% succeed without help.
Understanding withdrawal as a neurobiological phenomenon — and not as "lack of willpower" — is fundamental so that smokers seek and receive appropriate treatment. Effective treatments exist that triple the chances of successful cessation.
Neurochemical Dependence
Nicotine permanently alters dopaminergic reward circuits, creating physical and psychological dependence that explains the difficulty of cessation.
Temporary Symptoms
Physical withdrawal peaks at 2-3 days and improves significantly within 2-4 weeks. Symptoms are temporary but intense.
Effective Treatment
Nicotine replacement therapy, varenicline, and bupropion triple the chances of cessation. Adequate support makes all the difference.
Pathophysiology
Nicotine reaches the brain within 7-10 seconds after inhalation, binding to nicotinic acetylcholine receptors (nAChR) in the mesolimbic reward system. This triggers dopamine release in the nucleus accumbens — the same circuit activated by other drugs of abuse — producing pleasure and stress relief.
Neuroadaptation and Tolerance
With chronic exposure, the brain undergoes neuroadaptation: there is an increase in the number of nicotinic receptors (upregulation) to compensate for continuous desensitization. When the smoker stops smoking, these supernumerary receptors remain unoccupied, generating a state of dopaminergic hypoactivity that manifests as discomfort, irritability, and craving.
Multiple Neurotransmitters
Beyond dopamine, nicotine modulates the release of norepinephrine (alertness and concentration), serotonin (mood), GABA (relaxation), glutamate (memory), and endorphins (analgesia). Withdrawal affects all of these systems simultaneously, explaining the diversity of symptoms.
Symptoms
Withdrawal symptoms begin 2-12 hours after the last cigarette, peak at 24-72 hours, and gradually improve over 2-4 weeks. Some symptoms, such as craving and increased appetite, can persist for months. Intensity varies with the degree of dependence.
Symptoms of Nicotine Withdrawal
- 01
Intense craving for tobacco
Urgent and overwhelming desire to smoke. It usually lasts 3-5 minutes per episode but can be very intense. It is the main relapse factor.
- 02
Irritability, frustration, or anger
One of the most common and disturbing symptoms. It can significantly affect relationships and the work environment in the first weeks.
- 03
Anxiety
Paradoxically, anxiety worsens in the first weeks of cessation before improving. Nicotine was used as an "anxiolytic," and its withdrawal unmasks underlying anxiety.
- 04
Difficulty concentrating
Transient attentional deficit due to reduced norepinephrine. It can impair professional performance in the first 2-3 weeks.
- 05
Depressed mood
The reduction in dopamine causes transient anhedonia. In people with a history of depression, it can trigger a depressive episode.
- 06
Insomnia or sleep disturbances
Difficulty falling asleep, fragmented sleep, vivid dreams (especially with nicotine replacement). Improves in 1-2 weeks.
- 07
Increased appetite and weight gain
Average gain of 4-5 kg in the first months. Results from increased appetite, metabolic slowdown, and substitution of the oral habit.
- 08
Restlessness
Sensation of being unable to stay still, motor agitation. Related to dopaminergic hypoactivity.
- 09
Constipation
Nicotine stimulates intestinal peristalsis. Its withdrawal can cause transient constipation for 1-2 weeks.
Diagnosis
The diagnosis of nicotine dependence and withdrawal syndrome is clinical. The Fagerstrom Test for Nicotine Dependence (FTND) is the most widely used instrument to assess the degree of dependence and guide treatment selection. Serum or urinary cotinine can objectively confirm tobacco use.
🏥DSM-5 Criteria for Tobacco Withdrawal
Fonte: American Psychiatric Association — DSM-5
Criterion A: Daily tobacco use for at least several weeks
- 1.Daily tobacco use for a prolonged period before abrupt cessation or reduction
Criterion B: 4 or more symptoms within 24h after cessation
At least 4 symptoms must be present- 1.Irritability, frustration, or anger
- 2.Anxiety
- 3.Difficulty concentrating
- 4.Increased appetite
- 5.Restlessness
- 6.Depressed mood
- 7.Insomnia
Additional criteria
- 1.Symptoms cause clinically significant distress or functional impairment
- 2.Symptoms are not attributable to another medical condition or mental disorder
FAGERSTROM TEST — DEGREES OF DEPENDENCE
| SCORE | DEGREE OF DEPENDENCE | CLINICAL IMPLICATIONS |
|---|---|---|
| 0-2 | Low | May attempt cessation without pharmacotherapy. Behavioral support may be sufficient. |
| 3-4 | Moderate | Pharmacotherapy recommended. NRT at standard doses or bupropion. |
| 5-6 | High | Pharmacotherapy essential. Consider combination treatment. NRT at higher doses. |
| 7-10 | Very high | Combination therapy (NRT + bupropion or varenicline). Intensive follow-up. |
DIAGNÓSTICO DIFERENCIAL
Diagnóstico Diferencial
Depression
Leia mais →- Depressed mood persisting beyond the withdrawal period
- Generalized anhedonia
- Does not improve after weeks without smoking
Testes Diagnósticos
- PHQ-9
- Interview
GAD
Leia mais →- Anxiety persisting beyond withdrawal
- Multiple domains of worry
- Does not resolve after adaptation to withdrawal
Testes Diagnósticos
- GAD-7
Hypothyroidism (cause of weight gain)
- Disproportionate weight gain after cessation
- Persistent fatigue
- Abnormal TSH
Testes Diagnósticos
- TSH
Withdrawal Syndrome from Another Substance
- Concurrent use of alcohol/anxiolytics
- Symptoms more severe than expected for tobacco
Testes Diagnósticos
- Substance screening
Occupational Stress/Burnout
Leia mais →- Irritability and craving tied to the work context
- Worsening in work situations
Testes Diagnósticos
- Occupational evaluation
- MBI
Depression and Anxiety in Smoking Cessation
Smoking cessation can precipitate or reveal underlying depression and anxiety. Nicotine has antidepressant and anxiolytic effects — it increases dopamine, serotonin, and norepinephrine. On stopping smoking, withdrawal of these neurobiological effects can trigger depressed mood, anhedonia, and intensified anxiety, especially in the first 2-4 weeks. The clinical question is: are these symptoms nicotine withdrawal or an underlying psychiatric disorder?
Nicotine withdrawal peaks in the first 3-5 days and improves progressively over 2-4 weeks. If depressed mood, intense anhedonia, or anxiety persist beyond 4 weeks, an underlying psychiatric disorder should be investigated. PHQ-9 and GAD-7 are quick screening scales. Bupropion — a cessation pharmacotherapy — is also an antidepressant, which may mask underlying depression while cessation treatment is active.
Weight Gain and Hypothyroidism
Weight gain after smoking cessation is expected — on average 4-5 kg in the first 6-12 months. Nicotine suppresses appetite, increases basal metabolism, and reduces metabolic efficiency. Without these actions, metabolism slows and appetite increases. This gain is predictable and clinically far smaller than the ongoing risks of smoking.
When weight gain is disproportionate (above 8-10 kg) or accompanied by persistent fatigue, cold intolerance, and other complaints, hypothyroidism should be ruled out. A simple TSH guides the diagnosis. It is worth noting that smoking can mask hypothyroidism (nicotine interferes with thyroid metabolism), which becomes symptomatic after cessation. Treatment of hypothyroidism can facilitate maintenance of abstinence by resolving fatigue.
Context-Linked Craving and Polysubstance Use
Tobacco craving can be intense and is activated by specific contexts: stress at work, coffee or alcohol consumption, after meals, social situations. When craving and irritability are predominantly triggered by the occupational context, evaluating burnout or work stress as a precipitating factor is important — treating the stressor can reduce situational craving.
Polysubstance use complicates smoking cessation. Concurrent alcohol use reduces the chances of successful cessation by up to 50% — alcohol is a potent trigger for smoking. Benzodiazepines may mask early withdrawal symptoms. Screening for other substances (AUDIT for alcohol, ASSIST) is recommended in patients with withdrawal symptoms more intense than expected or multiple failed attempts.
Treatment
Smoking cessation treatment combines behavioral intervention and pharmacotherapy. The three first-line pharmacotherapies — nicotine replacement therapy (NRT), varenicline, and bupropion — are effective and safe. The combination of counseling and medication is more effective than any approach in isolation.
PHARMACOTHERAPY FOR SMOKING CESSATION
| TREATMENT | MECHANISM | CESSATION RATE (6 MONTHS) | CONSIDERATIONS |
|---|---|---|---|
| Varenicline (Champix) | Partial nAChR agonist — reduces craving and the pleasure of smoking | 25-35% | Most effective as monotherapy. Nausea is the most common side effect. |
| NRT (patch + gum/lozenge) | Nicotine replacement — reduces withdrawal without combustion | 20-25% | Combined forms (patch + rescue) are superior to a single form. |
| Bupropion | Inhibition of dopamine and norepinephrine reuptake | 15-25% | Especially useful with comorbid depression. Reduces weight gain. |
| Varenicline + NRT | Combination of mechanisms | 30-40% | Reserved for high dependence. Well tolerated in studies. |
Weeks 1-2 (pre-cessation)
Dependence assessment (Fagerstrom). Setting the quit date. Initiation of varenicline or bupropion (which require 1-2 weeks of titration before quitting).
Quit Day and Week 1
Abrupt cessation. Peak withdrawal (days 2-3). Full pharmacological support. Craving management techniques (rule of 4 Ds: delay, drink water, do something, deep breathe).
Weeks 2-4
Gradual improvement of physical symptoms. Maintenance of pharmacotherapy. Identification and management of behavioral triggers.
Months 1-3
Physical withdrawal resolved. Situational craving persists. Focus on relapse prevention and management of high-risk situations.
Months 3-6
Consolidation. Gradual NRT taper if applicable. Maintenance of varenicline for 12-24 weeks according to response.
Acupuncture as Treatment
Acupuncture, especially auriculotherapy, is widely used as a complementary therapy for smoking cessation. Proposed mechanisms include endorphin release that reduces craving, modulation of the dopaminergic reward system, parasympathetic activation via the vagus nerve, and reduction of anxiety associated with withdrawal.
Stimulation of specific auricular points may modulate vagus nerve activity and influence brain centers involved in dependence. Complementary body acupuncture may act on the reduction of stress and irritability — withdrawal symptoms that frequently precipitate relapse.
Acupuncture is used as a complement to conventional cessation therapies. It may be especially useful for patients who want an integrative approach or who have contraindications to conventional pharmacotherapy.
Prognosis
With appropriate treatment, long-term cessation rates (12 months) range from 20-35% — significantly better than the 3-5% seen without treatment. Most successful ex-smokers tried to quit more than once before succeeding definitively. Each attempt increases the chance of future success.
Health benefits begin quickly: in 20 minutes blood pressure normalizes, in 48 hours smell and taste improve, in 3 months lung function improves significantly. In 1 year, cardiovascular risk drops by half. In 10-15 years, the risk of lung cancer approaches that of nonsmokers.
Relapse is common and should not be seen as failure but as part of the recovery process. The period of greatest relapse risk is the first 3 months. Stressful situations, alcohol consumption, and exposure to other smokers are the most frequent triggers.
Myths and Facts
Myth vs. Fact
Quitting smoking is just a matter of willpower.
Nicotine dependence is a chronic disease with a neurobiological basis. Nicotine causes persistent neuroadaptations in reward circuits that make cessation extremely difficult without support. Pharmacological treatment triples the chances of success — needing help is not 'weakness'.
Myth vs. Fact
The e-cigarette is a safe way to quit smoking.
Although e-cigarettes contain fewer toxins than conventional cigarettes, they are not free of risk. Their long-term effects are still unknown. They are not approved as cessation treatment in most countries. Proven therapies such as varenicline, NRT, and bupropion are preferable.
Myth vs. Fact
Cutting down gradually is better than quitting all at once.
Evidence indicates that abrupt cessation has success rates equal to or greater than gradual reduction. Abrupt cessation with pharmacological support is the most studied and recommended method. However, for smokers who cannot quit abruptly, gradual reduction with NRT is a valid alternative.
When to Seek Help
If you want to quit smoking, the best time to seek help is now. Appropriate treatment makes all the difference. You do not have to go through this alone.
Frequently Asked Questions about Smoking Cessation
Symptoms of nicotine withdrawal include: intense craving — the most prominent symptom; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; depressed mood; increased appetite and weight gain; insomnia; and mild bradycardia. Symptoms peak at 24-72 hours and improve progressively over 2-4 weeks. Craving can persist for months, especially when activated by specific triggers (coffee, alcohol, stressful situations).
The combination of behavioral counseling and pharmacotherapy has the highest success rates — four times higher than trying to quit without help. The first-line pharmacotherapies are: Nicotine Replacement Therapy (NRT) in various forms (patch, gum, nasal spray, inhaler); varenicline (Champix) — a partial agonist of the nicotinic receptor and the most effective; and bupropion. Combinations (e.g., patch + nicotine gum) increase efficacy. Behavioral support (regular consultations, helplines) potentiates the medications.
Acupuncture — especially auriculotherapy (auricular acupuncture) — is studied as an adjunct in smoking cessation. Systematic reviews show mixed results, with some studies demonstrating reduction of craving and withdrawal symptoms. The proposed mechanism involves modulation of reward circuits (dopaminergic), reduction of anxiety and stress, and action on specific points related to the respiratory system. Acupuncture is best used as a complement to established pharmacotherapies, not as a substitute.
On average, smokers make 8-10 attempts before achieving definitive abstinence. This does not mean failure — each attempt offers learning about triggers, strategies that work, and strategies that do not. Relapse is part of the process for most people. The important message: relapsing is not "going back to square one" — each period of abstinence has health benefits. After a relapse, the ideal is to identify what triggered it, adjust the plan, and try again with more robust support.
E-cigarettes (vape/e-cigarettes) contain nicotine and are debated as harm-reduction tools. Some evidence suggests they may be more effective than NRT in certain studies, but the evidence is still limited and of variable quality. The UK NHS accepts their use as a cessation tool in supervised settings. In Brazil, the use of e-cigarettes is not regulated as a medication. Long-term risks are still unknown. Varenicline and NRT have more robust evidence and established regulation.
Weight gain is common but variable — averaging 4-5 kg in the first year. Mechanisms: nicotine suppresses appetite, increases basal metabolism, and reduces caloric absorption efficiency; without it, appetite increases and metabolism slows. Strategies to minimize: increase physical activity (which also reduces craving), maintain a regular diet without extreme restriction, replace the oral habit with healthy alternatives, and use pharmacotherapies that reduce weight gain (varenicline). Important: post-cessation weight gain is clinically irrelevant compared to the risks of continued smoking.
Recovery begins immediately: 20 minutes — BP and HR normalize; 8 hours — blood CO2 normalizes; 24 hours — risk of MI begins to fall; 48 hours — olfactory and gustatory nerves regenerate; 2 weeks — circulation and lung function improve; 1 month — cough and dyspnea decrease; 1 year — coronary disease risk drops 50%; 5 years — stroke risk equals that of a nonsmoker; 10 years — lung cancer risk drops 50%; 15 years — cardiovascular risk equals that of a nonsmoker.
Effective techniques to manage craving: the 5-minute rule — craving usually lasts less than 5 minutes; active distraction (physical activity, calling someone); diaphragmatic breathing techniques; moving away from the trigger; using NRT (fast-acting nicotine gum or spray) when craving is intense; recalling concrete reasons to quit; and recording the craving without acting ("surfing" the urge). Identifying and avoiding main triggers in the first weeks (alcohol, coffee in certain contexts) reduces exposure.
Yes, temporarily. Nicotine has a short-term anxiolytic effect — smokers frequently use the cigarette as an emotional regulator. In withdrawal, anxiety can increase in the first weeks while the nervous system readapts. The good news: longitudinal studies show that ex-smokers have LOWER baseline anxiety than active smokers after a few months of abstinence. The anxiety that seems to be reduced by the cigarette is partly nicotine withdrawal itself being relieved. Anxiety management techniques (breathing, mindfulness) and professional support help during this period.
Ideally, any smoker who wants to quit should seek medical support — success rates with assistance are much higher. Seeking help is especially recommended if: you have already tried to quit several times without success; there are psychiatric symptoms (depression, intense anxiety) associated with previous attempts; you use tobacco in large quantities (>20 cigarettes/day); there are cardiovascular or pulmonary diseases that make cessation urgent; or there is concurrent use of other substances. The physician can prescribe appropriate pharmacotherapy and coordinate behavioral support.
Related Reading
Deepen your knowledge with related articles